About Us
People
Insights
Publications
2024 Presidential Election
Cell and Gene
Inflation Reduction Act
Case Studies
Events
News
Videos
Solutions
Policy, Research, and Analysis
Market Access
Reimbursement
Strategic Analytics, Value and Economics
ADVI Databoard
Join Us
Get in Touch
Get in Touch
News
In The News
ADVI Director, Lindsay Bealor Greenleaf, talked with CNBC about the Administration’s proposed rule on rebates and what it could mean for drug prices and PBMs
In The News
Director Lindsay Bealor Greenleaf discussed concerns regarding Medicare Part B step therapy with FierceHealthcare
In The News
ADVI’s Lindsay Bealor Greenleaf talks to Bloomberg Law about Drug Pricing Reform Expectations Under the 116th Congress
In The News
ADVI’s Michael Kolodziej explains that the OCM could stimulate fine-tuned bundled payments and advance cancer care
In The News
ADVI’s Dr. Michael Kolodziej on physician impact of the Administration’s IPI Plan
In The News
ADVI director Lindsay Bealor Greenleaf talks changes to drug rebates and PBMs with the Washington Post
In The News
ADVI CEO Marc Samuels On FDA Commissioner Gottlieb’s Comments Related to CAR-T Label Change
In The News
Lindsay Bealor Greenleaf discusses the NDPC’s new pharmacy benefit contracting model with Managed Healthcare Executive
In The News
Lindsay Bealor Greenleaf Discusses the Top Healthcare Takeaways from the Midterm Elections with Managed Healthcare Executive
Posts pagination
< Previous page
1
…
18
19
20
…
25
Next page >